Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Congenital Abnormalities 1Blast Crisis 1

Interventions

fludarabine phosphate 32Peripheral Blood Stem Cell Transplantation 27Tacrolimus 26Cyclophosphamide 26Whole-Body Irradiation 25Busulfan 21Mycophenolic Acid 20Methotrexate 16Antilymphocyte Serum 16Melphalan 12Cyclosporine 9Cord Blood Stem Cell Transplantation 8Filgrastim 7Etoposide 7Thiotepa 6thymoglobulin 5merphos 5Sirolimus 5Rituximab 5Radiotherapy 5Methylprednisolone 5Cytarabine 5Granulocyte Colony-Stimulating Factor 4sargramostim 3fludarabine 3Flow Cytometry 3Transplantation 2Polymerase Chain Reaction 2Ondansetron 2Imatinib Mesylate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Accelerated Phase × Homoharringtonine × Clear all
NCT00114959 2015-01-15

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
15 enrolled 6 charts
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡